This compound is primarily utilized in the field of medical research, particularly in studies related to cardiovascular diseases. It functions as a selective inhibitor of the enzyme Lp-PLA2 (lipoprotein-associated phospholipase A2), which is implicated in the inflammation and destabilization of atherosclerotic plaques. By inhibiting this enzyme, it helps in reducing the risk of plaque rupture, which can lead to severe cardiovascular events such as heart attacks and strokes. Researchers use this compound to better understand the role of Lp-PLA2 in atherosclerosis and to explore potential therapeutic strategies for preventing or treating cardiovascular conditions. Its application is crucial in developing targeted therapies that can improve patient outcomes in cardiovascular health.